Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹105 Cr₹68 Cr₹109 Cr₹61 Cr₹9.13 Cr

What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH is ₹105 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹105 Cr
Mar2025₹68 Cr
Mar2024₹109 Cr
Mar2023₹61 Cr
Mar2022₹9.13 Cr

How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹105 Cr
53.89
Mar2025 ₹68 Cr
-37.42
Mar2024 ₹109 Cr
78.73
Mar2023 ₹61 Cr
567.74
Mar2022 ₹9.13 Cr -

Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,050.2 Cr 9.6% -2.5% -2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,831.0 Cr 2% 6% -6.7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

9.6%

-2.5%

-2%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses